Cuprina Holdings (Cayman) LTD
Close on Oct 19, 2026
About Cuprina Holdings (Cayman)
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Cuprina Holdings (Cayman) Limited is a biomedical and wound care company that develops, manufactures, and commercializes products for chronic wound management and skin health. The company operates across two principal segments: chronic wound care products and cosmeceutical products. Its flagship offerings include the MEDIFLY line of medical-grade sterile blowfly larvae bio-dressings for maggot debridement therapy, alongside a specialized range of cosmeceutical formulations. Cuprina serves institutional healthcare providers, including medical centers and hospitals, as well as individual consumers.
The company conducts business activities and maintains corporate subsidiaries in Singapore, Malaysia, mainland China, Hong Kong, and the United States, and also participates in a Middle East joint venture. It operates office premises and facilities in Singapore. The company maintains its principal executive offices and headquarters in Singapore.
Summary of the business section of Cuprina Holdings (Cayman)'s latest annual report, written by StockData.
Company profile
Company
- Legal name
- Cuprina Holdings (Cayman) LTD
- Founded
- 2019
- Headquarters
- Singapore, U0
- Address
- Block 1090, Lower Delta Road, #06-08 169201
- Phone
- (658) 512-7275
- Website
- cuprina.com.sg
- Employees
- 10, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- E9
- Fiscal year ends
- December 31
- Auditor
- Kreit & Chiu CPA LLP, Los Angeles, California
Stock & identifiers
- Ticker
- CUPR
- Exchange
- Nasdaq
- IPO date
- Apr 10, 2025
- Shares outstanding
- 7M, Apr 27, 2026
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-8 reverse, May 27, 2026
- SEC CIK
- 1995704
- CUSIP
- G2592E110
- ISIN
- USG2592E1105
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| David Yong Qi QUEK | Chief Executive Officer, Director | 3,119,859 |
| Tat Jing CHAN | Chief Financial Officer | – |
| Jimmy Peng Siew LEE | Director | 5,146,638 |
| Peng Kwang TEO | Director | 5,818,504 |
| Pee Keat KOH | Director | – |
| Natasha Kaur RAINA | Director | – |
| Wei Chean NG | Director | – |
Employees
Headcount reported in annual reports
“of December 31, 2025, we had 10 full-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 17, 2025 | Late filing | Notification of late filing |
| Apr 10, 2025 | IPO | Initial public offering priced (424B4 prospectus) |
| Apr 9, 2025 | Listing | Registration of securities on an exchange (Form 8-A) |
| Sep 26, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |